HealthCare Global Enterprises (NSE:HCG) EBIT: ₹2,035 Mil (TTM As of Mar. 2026)


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
79 GF Score
Price ₹600.40
GF Value ₹576.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises EBIT?

HealthCare Global Enterprises NSE:HCG -2.25% 79 EBIT is ₹2,035 Mil as of Mar. 2026. GuruFocus rates NSE:HCG with a GF Score™ of 79/100 and a GF Value™ of ₹576.14 (Fairly Valued). The stock has 2 warning signs investors should review.

HealthCare Global Enterprises's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹440 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,035 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. HealthCare Global Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 was 7.22%. HealthCare Global Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.54%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. HealthCare Global Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.99%.

HealthCare Global Enterprises  (NSE:HCG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

HealthCare Global Enterprises's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2490.8 * ( 1 - 0% )/( (0 + 34498.5)/ 1 )
=2490.8/34498.5
=7.22 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=39225.4 - 3546.4 - ( 5522.1 - max(0, 10171.6 - 11352.1+5522.1))
=34498.5

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

HealthCare Global Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1758/( ( (0 + max(0, 0)) + (20597.1 + max(-613.3, 0)) )/ 1 )
=1758/( ( 0 + 20597.1 )/ 1 )
=1758/20597.1
=8.54 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4207 + 598.2 + 991.2) - (3546.4 + 0 + 2863.3)
=-613.3

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

HealthCare Global Enterprises's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2034.9/102254.943
=1.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises EBIT Related Terms

HealthCare Global Enterprises EBIT Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises EBIT Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,745.42 1,392.75 1,684.23 2,115.20 2,034.90

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 577.90 573.90 634.40 387.10 439.50

NSE:HCG vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HealthCare Global Enterprises EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's EV-to-EBIT falls into.


NSE:HCG
79GF Score
HealthCare Global Enterprises Ltd NSE:HCG
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,035 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹2,035 Mil mean?
HealthCare Global Enterprises (NSE:HCG) has a EBIT of ₹2,035 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthCare Global Enterprises.
Is HealthCare Global Enterprises' EBIT too high?
HealthCare Global Enterprises' current EBIT is ₹2,035 Mil. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' EBIT compare to HCA and THC?
HealthCare Global Enterprises' EBIT of ₹2,035 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthCare Global Enterprises. HealthCare Global Enterprises's current EBIT is ₹2,035 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹576.14, compared to a current price of ₹600.40 — trading 4.2% above its estimated fair value. The current EBIT is ₹2,035 Mil. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current EBIT is ₹2,035 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹600.40 is trading 4.2% above its estimated GF Value™ of ₹576.14. GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.

Key valuation signals for NSE:HCG:

  • EBIT: ₹2,035 Mil
  • GF Value™: ₹576.14 vs. price of ₹600.40 (4.2% above fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score

Get the complete analysis for NSE:HCG

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹600.40
Price
₹576.14
GF Value